167 related articles for article (PubMed ID: 34681798)
41. Acutifoliside, a novel benzoic acid glycoside from Salix acutifolia.
Wu Y; Dobermann D; Beale MH; Ward JL
Nat Prod Res; 2016 Aug; 30(15):1731-9. PubMed ID: 26820172
[TBL] [Abstract][Full Text] [Related]
42. Anticarcinogenic effects of the ethanolic extract of Salix aegyptiaca in colon cancer cells: involvement of Akt/PKB and MAPK pathways.
Enayat S; Ceyhan MŞ; Başaran AA; Gürsel M; Banerjee S
Nutr Cancer; 2013; 65(7):1045-58. PubMed ID: 24168160
[TBL] [Abstract][Full Text] [Related]
43. Salicortin-derivatives from Salix pseudo-lasiogyne twigs inhibit adipogenesis in 3T3-L1 cells via modulation of C/EBPα and SREBP1c dependent pathway.
Lee M; Lee SH; Kang J; Yang H; Jeong EJ; Kim HP; Kim YC; Sung SH
Molecules; 2013 Aug; 18(9):10484-96. PubMed ID: 23999723
[TBL] [Abstract][Full Text] [Related]
44. Novel neurological and immunological targets for salicylate-based phytopharmaceuticals and for the anti-depressant imipramine.
Ulrich-Merzenich G; Kelber O; Koptina A; Freischmidt A; Heilmann J; Müller J; Zeitler H; Seidel MF; Ludwig M; Heinrich EU; Winterhoff H
Phytomedicine; 2012 Jul; 19(10):930-9. PubMed ID: 22743246
[TBL] [Abstract][Full Text] [Related]
45. Chemical composition of desert willow (Salix psammophila) grown in the Kubuqi Desert, Inner Mongolia, China: bark extracts associated with environmental adaptability.
Kubo S; Hashida K; Makino R; Magara K; Kenzo T; Kato A; Aorigele
J Agric Food Chem; 2013 Dec; 61(50):12226-31. PubMed ID: 24274758
[TBL] [Abstract][Full Text] [Related]
46. Effects of an ethanolic salix extract on the release of selected inflammatory mediators in vitro.
Fiebich BL; Chrubasik S
Phytomedicine; 2004 Feb; 11(2-3):135-8. PubMed ID: 15070163
[TBL] [Abstract][Full Text] [Related]
47. Dimeric procyanidins: screening for B1 to B8 and semisynthetic preparation of B3, B4, B6, And B8 from a polymeric procyanidin fraction of white willow bark (Salix alba).
Esatbeyoglu T; Wray V; Winterhalter P
J Agric Food Chem; 2010 Jul; 58(13):7820-30. PubMed ID: 20533825
[TBL] [Abstract][Full Text] [Related]
48. Drug-Drug Interaction Potential, Cytotoxicity, and Reactive Oxygen Species Production of
Gomes JVD; Herz C; Helmig S; Förster N; Mewis I; Lamy E
Front Pharmacol; 2021; 12():779801. PubMed ID: 34867410
[TBL] [Abstract][Full Text] [Related]
49. Bioactive Phytochemicals from
Kim HJ; Jang YS; Ha JW; Ra MJ; Jung SM; Yu JN; Kim K; Kim KH; Um SH
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233307
[No Abstract] [Full Text] [Related]
50. Pharmacokinetics of salicin after oral administration of a standardised willow bark extract.
Schmid B; Kötter I; Heide L
Eur J Clin Pharmacol; 2001 Aug; 57(5):387-91. PubMed ID: 11599656
[TBL] [Abstract][Full Text] [Related]
51. Willow bark extract STW 33-I in the long-term treatment of outpatients with rheumatic pain mainly osteoarthritis or back pain.
Uehleke B; Müller J; Stange R; Kelber O; Melzer J
Phytomedicine; 2013 Aug; 20(11):980-4. PubMed ID: 23731658
[TBL] [Abstract][Full Text] [Related]
52. Willow bark extract (BNO1455) and its fractions suppress growth and induce apoptosis in human colon and lung cancer cells.
Hostanska K; Jürgenliemk G; Abel G; Nahrstedt A; Saller R
Cancer Detect Prev; 2007; 31(2):129-39. PubMed ID: 17418981
[TBL] [Abstract][Full Text] [Related]
53. The bioguided fractionation and pharmacological activity of an endemic Salix canariensis species.
Gutiérrez SD; Kuri SA; Martín-Herrera D
Acta Pharm; 2017 Jun; 67(2):265-273. PubMed ID: 28590905
[TBL] [Abstract][Full Text] [Related]
54. In vitro degradation of willow salicylates.
Ruuhola T; Julkunen-Tiitto R; Vainiotalo P
J Chem Ecol; 2003 May; 29(5):1083-97. PubMed ID: 12857023
[TBL] [Abstract][Full Text] [Related]
55. Thin-layer chromatography and multivariate data analysis of willow bark extracts.
Wuthold K; Germann I; Roos G; Kelber O; Weiser D; Heinle H; Kovar KA
J Chromatogr Sci; 2004 Jul; 42(6):306-9. PubMed ID: 15296530
[TBL] [Abstract][Full Text] [Related]
56. Willow (
Reshamwala D; Shroff S; Liimatainen J; Tienaho J; Laajala M; Kilpeläinen P; Viherä-Aarnio A; Karonen M; Jyske T; Marjomäki V
Front Microbiol; 2023; 14():1249794. PubMed ID: 38029113
[TBL] [Abstract][Full Text] [Related]
57. Inter- and intraspecific diversity of Salix bark phenolic profiles - A resource for the pharmaceutical industry.
Köhler A; Förster N; Zander M; Ulrichs C
Fitoterapia; 2023 Oct; 170():105660. PubMed ID: 37648031
[TBL] [Abstract][Full Text] [Related]
58. Influence of willow bark extract on cyclooxygenase activity and on tumor necrosis factor alpha or interleukin 1 beta release in vitro and ex vivo.
Wagner I; Greim C; Laufer S; Heide L; Gleiter CH
Clin Pharmacol Ther; 2003 Mar; 73(3):272-4. PubMed ID: 12621392
[No Abstract] [Full Text] [Related]
59. Identification and accumulation of phenolic compounds in the leaves and bark of Salix alba (L.) and their biological potential.
Piątczak E; Dybowska M; Płuciennik E; Kośla K; Kolniak-Ostek J; Kalinowska-Lis U
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 33003576
[TBL] [Abstract][Full Text] [Related]
60. Flavan-3-ols and procyanidins from the bark of Salix purpurea L.
Jürgenliemk G; Petereit F; Nahrstedt A
Pharmazie; 2007 Mar; 62(3):231-4. PubMed ID: 17416202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
